What does CUSIP 67644C112 represent in this 13F holders report?

CUSIP 67644C112 is the security identifier for OCEAW - Ocean Biomedical, Inc. - *W EXP 02/14/202 used to aggregate holder disclosures.

How many institutions held OCEAW - Ocean Biomedical, Inc. - *W EXP 02/14/202 in Q1 2023?

20 institutional investors reported OCEAW - Ocean Biomedical, Inc. - *W EXP 02/14/202 for Q1 2023. Use the holders table for investor-level position and value details.

202 (OCEAW)

CUSIP: 67644C112

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / *W EXP 02/14/202
Total 13F shares: 2,421,692
Total 13F value: $677,555
Share change: +2,421,692
SEC-reported price per share: $0.28
Number of holders: 20
Value change: +$677,555
Number of buys: 20

Security key

67644C112

Report period

Q1 2023

Institutions

Top holders

OCEAW full security history Ownership snapshot Full 13F holder table Ocean Biomedical, Inc. SEC filings Ocean Biomedical, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OCEAW - Ocean Biomedical, Inc. - *W EXP 02/14/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Aesther Healthcare Sponso...

Disclosed value leader

—

Comparable rows

0/9

Latest evidence

22 Mar 2023

3/4/5 Some rows are evidence-backed but not safely comparable across classes. 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

SEC ownership evidence is available, but the rows are not safely comparable across share classes.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aesther Healthcare Sponsor, LLC's linked filing trail.

Detailed SEC evidence table Showing 1-6 of 9 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Aesther Healthcare Sponsor, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 2,625,000 shares	—	03 Nov 2021
Surendra K. Ajjarapu	3/4/5 Director 3/4/5	— mixed-class rows	— 3,082,252 shares mixed-class rows	—	22 Mar 2023
Michael L. Peterson	3/4/5 Director 3/4/5	— mixed-class rows	— 355,000 shares mixed-class rows	—	28 Feb 2023
Jack A. Elias	3/4/5 Director 3/4/5	— denominator unverified	— 75,000 shares	—	15 Feb 2023
Jerome Ringo	3/4/5 Director 3/4/5	— denominator unverified	— 75,000 shares	—	15 Feb 2023
Jonathan D. Kurtis	3/4/5 Director 3/4/5	— denominator unverified	— 75,000 shares	—	15 Feb 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,421,692

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %